Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a 6.054\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
[a] CCC(C(=O)NCc1ccccc1OC)n1nc(C)n2c(cc3occc32)c1=O
[b] CCOC(=O)C(Cc1cc(C(C)=O)ccc1OC(C)C)C(=O)OCC
Answer: a. CCC(C(=O)NCc1ccccc1OC)n1nc(C)n2c(cc3occc32)c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(C(=O)NCc1ccccc1OC)n1nc(C)n2c(cc3occc32)c1=O
CCC(C(=O)NCc1ccccc1OC)n1nc(C)n2c(cc3occc32)c1=O
N-[(2-methoxyphenyl)methyl]-2-(12-methyl-9-oxo-5-oxa-1,10,11-triazatricyclo[6.4.0.02,6]dodeca-2(6),3,7,11-tetraen-10-yl)butanamide